Concepedia

Girish Jayadeva

GJ

Statistics

Publications

7

Citations

198

H-Index

7

Active since

2004

Affiliations

Boehringer Ingelheim (Germany)(Current)

Temple University

Girish Jayadeva is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, rheumatology, and immunotherapy.

Publications per year

2004–2022

7

Publications

7

A Dynamic Equilibrium between CDKs and PP2A Modulates Phosphorylation of pRB, p107 and p130

Judit Garriga, Arun L. Jayaraman, Ana Limón et al. · Cell Cycle · 2004 · 56 citations · Full text

, , +14

B55α PP2A Holoenzymes Modulate the Phosphorylation Status of the Retinoblastoma-related Protein p107 and Its Activation

Girish Jayadeva, Alison Kurimchak, Judit Garriga et al. · Journal of Biological Chemistry · 2010 · 38 citations · Full text

, , +17

Population pharmacokinetics of adalimumab biosimilar adalimumab‐adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity

Jia Kang, Rena J. Eudy‐Byrne, John Mondick et al. · British Journal of Clinical Pharmacology · 2020 · 27 citations · Full text

, , +17

Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext)

Stanley Cohen, Niklas Czeloth, Eric Lee et al. · Expert Opinion on Biological Therapy · 2019 · 24 citations · Full text

, , +17

Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study

Alan Menter, Petr Arenberger, Sigrid Balser et al. · Expert Opinion on Biological Therapy · 2020 · 20 citations · Full text

, , +12

1–5 of 7